Skip to Main Content

Botswana's Mass Antiretroviral Therapy Program

2016

This case study describes the impact of Botswana’s distribution of free anti-retroviral treatment (ART) to its citizens. In 2002, the Botswana government’s National AIDS Coordinating Agency (NACA) began distributing ART drugs, donated by Merck, free of charge. This case describes key factors contributing to the increased uptake of ART across the country, changes in the government-defined ART regimen and eligibility criteria over time, and the impact of the program on health outcomes and costs.

This case study is part of Millions Saved: New Cases of Proven Success in Global Health, a collection of case studies produced by the Center for Global Development that profiles 18 remarkable cases in which large-scale efforts to improve health in low- and middle-income countries succeeded, and 4 examples of promising interventions that fell short of their health targets when scaled-up in real world conditions. The cases featured on the website are shortened versions of the respective book chapters in the print edition.

Source:

Glassman A, Temin M. Botswana’s Mass Antiretroviral Therapy Program. Millions Saved: New Cases of Proven Success in Global Health. Center for Global Development 2016. http://millionssaved.cgdev.org/case-studies/botswanas-mass-antiretroviral-therapy-program.